Your browser doesn't support javascript.
loading
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasis.
Barriga, Francisco M; Tsanov, Kaloyan M; Ho, Yu-Jui; Sohail, Noor; Zhang, Amy; Baslan, Timour; Wuest, Alexandra N; Del Priore, Isabella; Meskauskaite, Brigita; Livshits, Geulah; Alonso-Curbelo, Direna; Simon, Janelle; Chaves-Perez, Almudena; Bar-Sagi, Dafna; Iacobuzio-Donahue, Christine A; Notta, Faiyaz; Chaligne, Ronan; Sharma, Roshan; Pe'er, Dana; Lowe, Scott W.
Afiliação
  • Barriga FM; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tsanov KM; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ho YJ; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sohail N; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhang A; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Baslan T; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wuest AN; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Del Priore I; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, New York, NY, USA.
  • Meskauskaite B; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Livshits G; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Alonso-Curbelo D; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Simon J; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chaves-Perez A; Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Bar-Sagi D; Department of Biochemistry, New York University School of Medicine, New York, NY, USA.
  • Iacobuzio-Donahue CA; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Notta F; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Chaligne R; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Sharma R; Division of Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Pe'er D; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Lowe SW; Program for Computational and Systems Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Cancer ; 3(11): 1367-1385, 2022 11.
Article em En | MEDLINE | ID: mdl-36344707

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Interferons / Neoplasias Limite: Animals Idioma: En Revista: Nat Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Interferons / Neoplasias Limite: Animals Idioma: En Revista: Nat Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos